{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:03:07Z","timestamp":1794290587290,"version":"4.9.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-025-11847-z","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T09:59:52Z","timestamp":1755251992000},"page":"1240-1252","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Significant dose reduction employing dual-low-dose PET\/CT in pediatric lymphoma: maintaining diagnostic, staging, and response-assessing efficacy"],"prefix":"10.1007","volume":"36","author":[{"given":"Yuqian","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shatong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuyi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingfan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0164-3510","authenticated-orcid":false,"given":"Yingying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,15]]},"reference":[{"key":"11847_CR1","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1093\/jnci\/djad115","volume":"115","author":"DA Siegel","year":"2023","unstructured":"Siegel DA, King JB, Lupo PJ et al (2023) Counts, incidence rates, and trends of pediatric cancer in the United States, 2003\u20132019. J Natl Cancer Inst 115:1337\u20131354","journal-title":"J Natl Cancer Inst"},{"key":"11847_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ped4.12279","volume":"5","author":"Z Li","year":"2021","unstructured":"Li Z, Zheng R, Xu X et al (2021) Pediatric cancer surveillance in China: a hospital-based introduction. Pediatr Invest 5:81\u201385","journal-title":"Pediatr Invest"},{"key":"11847_CR3","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1200\/JCO.2014.59.4853","volume":"33","author":"C Mauz-K\u00f6rholz","year":"2015","unstructured":"Mauz-K\u00f6rholz C, Metzger ML, Kelly KM et al (2015) Pediatric Hodgkin lymphoma. J Clin Oncol 33:2975\u20132985","journal-title":"J Clin Oncol"},{"key":"11847_CR4","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1200\/JCO.2014.59.5827","volume":"33","author":"V Minard-Colin","year":"2015","unstructured":"Minard-Colin V, Brugi\u00e8res L, Reiter A et al (2015) Non-Hodgkin lymphoma in children and adolescents: progress through effective collaboration, current knowledge, and challenges ahead. J Clin Oncol 33:2963\u20132974","journal-title":"J Clin Oncol"},{"key":"11847_CR5","doi-asserted-by":"publisher","first-page":"733","DOI":"10.6004\/jnccn.2021.0027","volume":"19","author":"JE Flerlage","year":"2021","unstructured":"Flerlage JE, Hiniker SM, Armenian S et al (2021) Pediatric Hodgkin lymphoma, version 3.2021. J Natl Compr Canc Netw 19:733\u2013754","journal-title":"J Natl Compr Canc Netw"},{"key":"11847_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2967\/jnumed.122.264106","volume":"64","author":"F Ricard","year":"2023","unstructured":"Ricard F, Cheson B, Barrington S et al (2023) Application of the Lugano classification for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the PRoLoG consensus initiative (Part 1\u2014Clinical). J Nucl Med 64:102\u2013108","journal-title":"J Nucl Med"},{"key":"11847_CR7","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.2967\/jnumed.118.222299","volume":"60","author":"JJ Cerci","year":"2019","unstructured":"Cerci JJ, Etchebehere EC, Nadel H et al (2019) Is true whole-body 18F-FDG PET\/CT required in pediatric lymphoma? An IAEA multicenter prospective study. J Nucl Med 60:1087\u20131093","journal-title":"J Nucl Med"},{"key":"11847_CR8","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.2967\/jnumed.108.054130","volume":"50","author":"FH Fahey","year":"2009","unstructured":"Fahey FH (2009) Dosimetry of pediatric PET\/CT. J Nucl Med 50:1483\u20131491","journal-title":"J Nucl Med"},{"key":"11847_CR9","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1038\/s41591-023-02620-0","volume":"29","author":"M Bosch de Basea","year":"2023","unstructured":"Bosch de Basea M, Thierry-Chef I, Harbron R et al (2023) Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults. Nat Med 29:3111\u20133119","journal-title":"Nat Med"},{"key":"11847_CR10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s11307-021-01601-4","volume":"23","author":"H Kert\u00e9sz","year":"2021","unstructured":"Kert\u00e9sz H, Beyer T, London K et al (2021) Reducing radiation exposure to paediatric patients undergoing [18F]FDG-PET\/CT imaging. Mol Imaging Biol 23:775\u2013786","journal-title":"Mol Imaging Biol"},{"key":"11847_CR11","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1053\/j.semnuclmed.2017.01.002","volume":"47","author":"MT Parisi","year":"2017","unstructured":"Parisi MT, Bermo MS, Alessio AM, Sharp SE, Gelfand MJ, Shulkin BL (2017) Optimization of pediatric PET\/CT. Semin Nucl Med 47:258\u2013274","journal-title":"Semin Nucl Med"},{"key":"11847_CR12","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.2967\/jnumed.116.182899","volume":"58","author":"FH Fahey","year":"2017","unstructured":"Fahey FH, Goodkind A, MacDougall RD et al (2017) Operational and dosimetric aspects of pediatric PET\/CT. J Nucl Med 58:1360\u20131366","journal-title":"J Nucl Med"},{"key":"11847_CR13","doi-asserted-by":"crossref","first-page":"15N","DOI":"10.2967\/jnumed.115.162966","volume":"57","author":"ST Treves","year":"2016","unstructured":"Treves ST, Gelfand MJ, Fahey FH, Parisi MT (2016) 2016 Update of the North American consensus guidelines for pediatric administered radiopharmaceutical activities. J Nucl Med 57:15N\u201318N","journal-title":"J Nucl Med"},{"key":"11847_CR14","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1007\/s00259-019-04624-w","volume":"47","author":"GL Poli","year":"2020","unstructured":"Poli GL, Torres L, Coca M et al (2020) Paediatric nuclear medicine practice: an international survey by the IAEA. Eur J Nucl Med Mol Imaging 47:1552\u20131563","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"11847_CR15","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2967\/jnumed.120.250597","volume":"62","author":"BA Spencer","year":"2021","unstructured":"Spencer BA, Berg E, Schmall JP et al (2021) Performance evaluation of the uEXPLORER total-body PET\/CT scanner based on NEMA NU 2-2018 with additional tests to characterize PET scanners with a long axial field of view. J Nucl Med 62:861\u2013870","journal-title":"J Nucl Med"},{"key":"11847_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2967\/jnumed.119.226498","volume":"60","author":"RD Badawi","year":"2019","unstructured":"Badawi RD, Shi H, Hu P et al (2019) First human imaging studies with the EXPLORER total-body PET scanner. J Nucl Med 60:299\u2013303","journal-title":"J Nucl Med"},{"key":"11847_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2967\/jnumed.116.184028","volume":"59","author":"SR Cherry","year":"2018","unstructured":"Cherry SR, Jones T, Karp JS, Qi J, Moses WW, Badawi RD (2018) Total-body PET: maximizing sensitivity to create new opportunities for clinical research and patient care. J Nucl Med 59:3\u201312","journal-title":"J Nucl Med"},{"key":"11847_CR18","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2967\/jnumed.121.262038","volume":"63","author":"Y Hu","year":"2022","unstructured":"Hu Y, Liu G, Yu H et al (2022) Feasibility of acquisitions using total-body PET\/CT with an ultra-low 18F-FDG activity. J Nucl Med 63:959\u2013965","journal-title":"J Nucl Med"},{"key":"11847_CR19","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1007\/s00259-021-05537-3","volume":"49","author":"H Tan","year":"2022","unstructured":"Tan H, Cai D, Sui X et al (2022) Investigating ultra-low-dose total-body [18F]-FDG PET\/CT in colorectal cancer: initial experience. Eur J Nucl Med Mol Imaging 49:1002\u20131011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"11847_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2967\/jnumed.119.240127","volume":"62","author":"JP Schmall","year":"2021","unstructured":"Schmall JP, Surti S, Otero HJ, Servaes S, Karp JS, States LJ (2021) Investigating low-dose image quality in whole-body pediatric 18F-FDG scans using time-of-flight PET\/MRI. J Nucl Med 62:123\u2013130","journal-title":"J Nucl Med"},{"key":"11847_CR21","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1007\/s00259-020-05091-4","volume":"48","author":"H Tan","year":"2021","unstructured":"Tan H, Sui X, Yin H et al (2021) Total-body PET\/CT using half-dose FDG and compared with conventional PET\/CT using full-dose FDG in lung cancer. Eur J Nucl Med Mol Imaging 48:1966\u20131975","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"11847_CR22","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1007\/s00259-021-05304-4","volume":"48","author":"YM Zhao","year":"2021","unstructured":"Zhao YM, Li YH, Chen T et al (2021) Image quality and lesion detectability in low-dose pediatric 18F-FDG scans using total-body PET\/CT. Eur J Nucl Med Mol Imaging 48:3378\u20133385","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"11847_CR23","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1007\/s00259-022-05893-8","volume":"49","author":"W Chen","year":"2022","unstructured":"Chen W, Liu L, Li Y et al (2022) Evaluation of pediatric malignancies using total-body PET\/CT with half-dose [18F]FDG. Eur J Nucl Med Mol Imaging 49:4145\u20134155","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"11847_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2967\/jnumed.120.254110","volume":"62","author":"R Vali","year":"2021","unstructured":"Vali R, Alessio A, Balza R et al (2021) SNMMI procedure standard\/EANM practice guideline on pediatric 18F-FDG PET\/CT for oncology 1.0. J Nucl Med 62:99\u2013110","journal-title":"J Nucl Med"},{"key":"11847_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00259-020-04928-2","volume":"48","author":"V Bertolini","year":"2021","unstructured":"Bertolini V, Trojani V, Bertolini M (2021) CT protocol optimisation in PET\/CT: what we learn from a systematic review. Eur J Nucl Med Mol Imaging 48:1\u20132","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"11847_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s40658-020-00287-x","volume":"7","author":"V Bertolini","year":"2020","unstructured":"Bertolini V, Palmieri A, Bassi MC et al (2020) CT protocol optimisation in PET\/CT: a systematic review. EJNMMI Phys 7:17","journal-title":"EJNMMI Phys"},{"key":"11847_CR27","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1148\/radiol.210551","volume":"303","author":"B Jiang","year":"2022","unstructured":"Jiang B, Li N, Shi X et al (2022) Deep learning reconstruction shows better lung nodule detection for ultra-low-dose chest CT. Radiology 303:202\u2013212","journal-title":"Radiology"},{"key":"11847_CR28","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1007\/s00330-022-09145-z","volume":"33","author":"S Tang","year":"2023","unstructured":"Tang S, Hu Y, Zeng J et al (2023) Significant CT dose reduction of 2-[18F]FDG PET\/CT in pretreatment pediatric lymphoma without compromising the diagnostic and staging efficacy. Eur Radiol 33:2248\u20132257","journal-title":"Eur Radiol"},{"key":"11847_CR29","doi-asserted-by":"publisher","unstructured":"(2007) The 2007 recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP 37:1\u2013332 https:\/\/doi.org\/10.1016\/j.icrp.2007.10.003","DOI":"10.1016\/j.icrp.2007.10.003"},{"key":"11847_CR30","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1148\/radiol.10100047","volume":"257","author":"PD Deak","year":"2010","unstructured":"Deak PD, Smal Y, Kalender WA (2010) Multisection CT protocols: sex- and age-specific conversion factors used to determine effective dose from dose-length product. Radiology 257:158\u2013166","journal-title":"Radiology"},{"key":"11847_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/0146645314558019","volume":"44","author":"S Mattsson","year":"2015","unstructured":"Mattsson S, Johansson L, Leide Svegborn S et al (2015) Radiation dose to patients from radiopharmaceuticals: a compendium of current information related to frequently used substances. Ann ICRP 44:7\u2013321","journal-title":"Ann ICRP"},{"key":"11847_CR32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.diii.2021.02.006","volume":"102","author":"B Nicolan","year":"2021","unstructured":"Nicolan B, Greffier J, Dabli D et al (2021) Diagnostic performance of ultra-low dose versus standard dose CT for non-traumatic abdominal emergencies. Diagn Interv Imaging 102:379\u2013387","journal-title":"Diagn Interv Imaging"},{"key":"11847_CR33","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.2967\/jnumed.116.181347","volume":"58","author":"SF Barrington","year":"2017","unstructured":"Barrington SF, Johnson PWM (2017) 18F-FDG PET\/CT in lymphoma: has imaging-directed personalized medicine become a reality? J Nucl Med 58:1539\u20131544","journal-title":"J Nucl Med"},{"key":"11847_CR34","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1007\/s00259-009-1306-7","volume":"37","author":"D Vriens","year":"2010","unstructured":"Vriens D, Visser EP, de Geus-Oei LF, Oyen WJ (2010) Methodological considerations in quantification of oncological FDG PET studies. Eur J Nucl Med Mol Imaging 37:1408\u20131425","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11847-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-11847-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11847-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T09:26:11Z","timestamp":1772443571000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-11847-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,15]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["11847"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-11847-z","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,15]]},"assertion":[{"value":"31 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Yuqian Huang.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"Author Tingfan Wu is an employee of the Central Research Institute, United Imaging Healthcare. Other authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all patients\u2019 legal guardians in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No study subjects or cohorts have been previously reported.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}